Navigation Links
MRSA in hospital intensive care -- what's growing where?
Date:3/30/2008

Researchers are finding out which bugs grow in intensive care units to develop a novel sampling regime that would indicate the threat of MRSA and other superbugs in the environment, scientists heard today (Monday 31 March 2008) at the Society for General Microbiologys 162nd meeting being held this week at the Edinburgh International Conference Centre.

We are developing a standard sampling regime to take swabs from sinks, taps, floors and other surfaces like computer keyboards, and use these to identify accurately which superbug genes are present in an intensive care unit, says Gemma Kay from Sheffield Hallam University in South Yorkshire. Critically ill patients in the intensive care unit are particularly at risk from hospital acquired infections.

The university research team has been working with clinical collaborators at the Sheffield Teaching Hospitals Trust to develop infection control procedures which could protect vulnerable patients and help to manage any future superbug outbreaks.

Our technique allows us to characterise the genes from micro-organisms using a gene amplification technique called polymerase chain reaction (PCR). This lets us expand tiny samples enough to identify individual strains of bacteria, and to spot particular antibiotic resistance genes, says Gemma Kay.

Our findings so far, from routine samples taken from the intensive care unit and patients screened over the last 12 months, show extremely low levels of MRSA (methicillin resistant Staphylococcus aureus), known drug resistant bacteria such as Clostridium difficile and other strains of bacteria that can make extended spectrum beta lactamase, which are all resistant to antibiotics commonly used to treat infections, says Gemma Kay.

Patients in intensive care units are particularly vulnerable to drug resistant infections, which can worsen their condition, prolong their stay and require heavy antibiotic regimes, diverting significant resources from the hospital budget. To date frequencies of resistant infections in the intensive care unit have been extremely low.

By establishing which organisms and which drug resistance genes are circulating in the intensive care unit we will be able to see to what extent the environment is a potential infection threat to patients, says Gemma Kay. Our experience so far suggests very good infection control, but the final outcomes of the study may suggest further changes that could provide additional protection for patients.


'/>"/>

Contact: Lucy Goodchild
l.goodchild@sgm.ac.uk
44-011-898-81843
Society for General Microbiology
Source:Eurekalert

Related biology news :

1. Texas Hospital nations first to use large-scale cocoon strategy against whooping cough
2. Pennsylvania Hospital recognized for excellence in bariatric surgery
3. Childrens Hospital neurosurgeon receives grant
4. Pennsylvania Hospital surgeon receives grant to develop molecular cardiac surgery
5. Childrens Hospital studying drug with the potential to prevent/delay onset of type 1 diabetes
6. Nationwide Childrens Hospital involved in expanded access program for treatment of PKU
7. 3 out of 4 hospital patients suffer from malnutrition regardless of their pathology
8. Seattle Childrens Hospital leads $23.7 million NIH grant to study gene repair
9. Study finds environmental tests help predict hospital-acquired Legionnaires disease risk
10. Will intensive forest practices impact water quality?
11. Research project aims to control sunlight, extend growing season and conserve energy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/13/2017)... 2017  RSA Conference -- RSA, a Dell Technologies ... to enhance fraud detection and investigation across digital ... Fraud & Risk Intelligence Suite. The new platform ... insights from internal and external sources as well ... customers from targeted cybercrime attacks. "Fraudsters ...
(Date:2/10/2017)... -- Research and Markets has announced the ... Scientific and Commercial Aspects" to their offering. ... Biomarkers play ... therapy for selection of treatment as well for monitoring the ... disease in modern medicine. Biochip/microarray technologies and next generation sequencing ...
(Date:2/8/2017)... , Feb. 8, 2017 About Voice ... voice to match it against a stored voiceprint ... as pitch, cadence, and tone are compared to ... minimal hardware installation, as most PCs already have ... different transactions. Voice recognition biometrics are most likely ...
Breaking Biology News(10 mins):
(Date:3/24/2017)... 24, 2017   Sienna Biopharmaceuticals, Inc. , a ... announced that Richard Peterson will join the ... Peterson, who brings more than two decades of ... who is retiring at the end of April but ... Peterson joins Sienna from Novan, Inc., where he served ...
(Date:3/23/2017)... 2017 Research and Markets has announced ... report to their offering. ... The Global Market for Bioproducts Should ... at a CAGR of 8.9%, This research ... into seven major product segments: bio-derived chemicals, biofuels, pharmaceuticals (biodrugs ...
(Date:3/23/2017)... March 23, 2017  BioPharmX Corporation (NYSE MKT: ... the dermatology market, today reported financial results for ... and will provide an update on the company,s ... "We are pleased to report that ... BioPharmX," said President Anja Krammer. "We achieved key ...
(Date:3/23/2017)... According to a report by Transparency Market Research (TMR), ... the presence of a large pool of participants; however, only a ... Sigma-Aldrich, compete with each other in this market. With Proliant being ... of this market in 2016.  ... As of now, a large number of vendors are ...
Breaking Biology Technology: